Class II Device Recall: GEM Premier 5000
Summary
The FDA has issued a Class II device recall for Instrumentation Laboratory's GEM Premier 5000, Part No. 00055445004. The recall is due to an increased incidence of 'Process Control Solution Not Detected' errors with the GEM PAK cartridges, potentially leading to GEM PAK ejection. The device is distributed worldwide.
What changed
The FDA has initiated a Class II device recall for the GEM Premier 5000, manufactured by Instrumentation Laboratory. The recall, identified as Z-1541-2026, addresses customer complaints of an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors with the GEM PAK cartridges during warm-up. These errors can lead to GEM PAK ejection, requiring the insertion of new cartridges and potentially impacting patient care.
This recall affects worldwide distribution, including the US and several other countries. Healthcare providers and medical device manufacturers using or distributing this product should review the recall details and take appropriate action. While the document does not specify a compliance deadline, entities involved in the distribution or use of this device should consult the FDA's openFDA Enforcement API for further guidance and to understand their reporting obligations. Non-compliance with recall procedures can lead to regulatory action.
What to do next
- Review recall details for GEM Premier 5000, Part No. 00055445004.
- Consult openFDA Enforcement API for specific actions and reporting obligations.
- Implement corrective actions as per FDA guidance for Class II recalls.
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1541-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Part No. 00055445004.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.